Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus.

× No keyword cloud information.

3 in total

Review 1. Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.

Authors: Alessandro Caracciolo; Renato Francesco Maria Scalise; Fabrizio Ceresa; Gianluca Bagnato; Antonio Giovanni Versace; Roberto Licordari; Silvia Perfetti; Francesca Lofrumento; Natasha Irrera; Domenico Santoro; Francesco Patanè; Gianluca Di Bella; Francesco Costa; Antonio Micari
Journal: J Clin Med Date: 2022-04-23 Impact factor: 4.964

2. Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia.

Authors: Tianyu Jia; Jingan Rao; Lifang Zou; Shanhong Zhao; Zhihua Yi; Bing Wu; Lin Li; Huilong Yuan; Liran Shi; Chunping Zhang; Yun Gao; Shuangmei Liu; Hong Xu; Hui Liu; Shangdong Liang; Guilin Li
Journal: Front Neurosci Date: 2018-01-25 Impact factor: 4.677

3. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y₁₂ Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.

Authors: Francesco Franchi; Stefan K James; Tatevik Ghukasyan Lakic; Andrzej J Budaj; Jan H Cornel; Hugo A Katus; Matyas Keltai; Frederic Kontny; Basil S Lewis; Robert F Storey; Anders Himmelmann; Lars Wallentin; Dominick J Angiolillo
Journal: J Am Heart Assoc Date: 2019-03-19 Impact factor: 5.501

3 in total

Impact of chronic kidney disease on platelet P2Y12 receptor signalling in patients with type 2 diabetes mellitus.

Review 1. Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease.

2. Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia.

3. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.

Impact of chronic kidney disease on platelet P2Y₁₂ receptor signalling in patients with type 2 diabetes mellitus.

3. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y₁₂ Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.